Skip to content

BIOGEM

Active Private limited companyfounded 2011active for 15 yearsBihain 28, 6690 VielsalmKBO/BCE: BE 0838.015.860

Lifetime

14 annual accounts with figures on one time axis
peak of €92,587 in 2019
€88,985▲ 3.0%
lowest -€57,004 in 2013
-€16,446▼ €3,712
peak of €121,050 in 2016
€37,130▲ €103,554
€145,883▼ 44.3%
peak of 3.3 FTE in 2019
-not published
Board2 names since 2011
- 
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Loss of €16,4461 director resigning 28-02Equity from -€66,424 to €37,130Debts from €261,965 to €145,883

Key points

from the 2025 annual accounts

Equity

€37,130 from €121,050 in 2016

Equity fell by 69% in 9 years.

Losses

-€148,370 in five years
-32,6662021-30,8312022-55,6922023-12,7342024-16,4462025

Every financial year from 2021 to 2025 closed with a loss. 2023 was the heaviest.

Debts

€145,883 80% of the balance sheet
Financial debts 0%Suppliers 17%Taxes and wages 5%Other 79%
2025 accounts filed 31 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,168 companies had the same profile as BIOGEM has now. Each dot stands for 6 companies, two years later.

94.1%
were still trading
3.1%
stopped another way
2.5%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a small loss

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,168 companies, not a prediction for BIOGEM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Director, until 2025
  • 650 sharesdeed of 01-03-2016
  • 650 sharesdeed of 01-03-2016
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0838015860
1 director resigning changes role from manager to director · resigns · acts as permanent representative · Gazette deed
New establishment in Virton Rue des Cormorans 2Z
Capital increase of €130,000 to €248,600 The capital rose from €118,600 to €248,600, with 1,300 new shares · 650 shares · General meeting of 28-01-2016 · Gazette deed
All 27 events

Comparable companies

same main activity, similar in size and age
Company
BIOGEM Vielsalm €183,013 €88,985 20.3% -
LBS Ghent €291,800 €99,629 20.8% -
Alchemich Farma Houthalen-Helchteren €258,120 €51,607 9.6% -
PARC ELISABETH PHARMA Ganshoren €296,304 €41,547 -21.4% -
MAYAKU PHARMACEUTICAL DEVELOPMENT Ghent €170,483 €104,752 0.8% -
CHARTA Gembloux €422,145 €113,461 17.7% -
Dierenartsen Hond en Kat Deinze €321,318 €80,014 0.7% -

These companies have the same main activity as BIOGEM: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €170,000 and €422,000, founded between 1992 and 2020.

Official details

Source: KBO
Status
Active since 20-07-2011Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201and 1 other
Joint committee
145Horticulture · annual accounts 2023
Establishment units
2.201.967.6036690 Vielsalm, since 01-08-2011
2.255.765.7816761 Virton, since 01-09-2016
Financial year end
31 December
Peppol
Reachable since 04-12-2025
Company details

Annual accounts 2025

≈ €260,000estimated
€183,013▼ 6.4%
≈ 2.6 FTEestimated
Filing
Filed on 31-08-2026
Financials

Insights on BIOGEM

BIOGEM files the micro format. That format states no turnover. The gross margin rose from €14,546 in 2012 to €88,985 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BIOGEM

What is the company number of BIOGEM?
The company number of BIOGEM is 0838.015.860. The VAT number is the same number with BE in front: BE 0838.015.860.
Where is BIOGEM based?
The registered office is at Bihain 28, 6690 Vielsalm.Company details
What does BIOGEM do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
What is the legal form of BIOGEM?
BIOGEM is a private limited company (BV).
When was BIOGEM founded?
BIOGEM was founded on 20-07-2011.
Is BIOGEM still active?
Yes, BIOGEM is an active enterprise in the KBO register.
How many employees does BIOGEM have?
BIOGEM had an average of 2.9 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does BIOGEM fall under?
In its 2023 annual accounts, BIOGEM states joint committee 145 (Horticulture).
What is the turnover of BIOGEM?
The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €88,985 and 2,981 comparable companies of the same size. It probably lies between €170,000 and €460,000. It is a rough estimate.
Is BIOGEM profitable?
In financial year 2025, BIOGEM made a loss of €16,446.
Where can I find the annual accounts of BIOGEM?
BIOGEM filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIOGEM due?
BIOGEM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.